Assignee
VEROSCIENCE LLC
US32 patents
Top patents by PatentIndex Score
US9192576B2Nov 24, 2015
Bromocriptine formulations
VEROSCIENCE LLC30 citations97
US10675282B2Jun 9, 2020
Method of treating metabolic disorders and depression with dopamine receptor agonists
VEROSCIENCE LLC11 citations94
US9205084B2Dec 8, 2015
Method of treating metabolic disorders and depression with dopamine receptor agonists
VEROSCIENCE LLC28 citations94
US11000522B2May 11, 2021
Bromocriptine formulations
VEROSCIENCE LLC10 citations93
US10688094B2Jun 23, 2020
Bromocriptine formulations
VEROSCIENCE LLC11 citations93
US10238653B2Mar 26, 2019
Method of treating metabolic disorders and depression with dopamine receptor agonists
VEROSCIENCE LLC12 citations93
US9925186B2Mar 27, 2018
Method of treating metabolic disorders and depression with dopamine receptor agonists
VEROSCIENCE LLC11 citations93
US9352025B2May 31, 2016
Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders
VEROSCIENCE LLC21 citations93
US8613947B2Dec 24, 2013
Bromocriptine formulations
VEROSCIENCE LLC32 citations93
US10307421B2Jun 4, 2019
Bromocriptine formulations
VEROSCIENCE LLC11 citations92
US9993474B2Jun 12, 2018
Bromocriptine formulations
VEROSCIENCE LLC11 citations92
US9700555B2Jul 11, 2017
Bromocriptine formulations
VEROSCIENCE LLC12 citations92
US9522117B2Dec 20, 2016
Bromocriptine formulations
VEROSCIENCE LLC12 citations92
US11883399B2Jan 30, 2024
Bromocriptine formulations
VEROSCIENCE LLC5 citations86
US11878974B2Jan 23, 2024
Composition and method for treating metabolic disorders
VEROSCIENCE LLC4 citations86
US11607455B2Mar 21, 2023
Method for inducing tumor regression
VEROSCIENCE LLC6 citations86
US11560375B2Jan 24, 2023
Composition and method for treating metabolic disorders
VEROSCIENCE LLC6 citations86
US11510921B2Nov 29, 2022
Bromocriptine formulations
VEROSCIENCE LLC7 citations86
US11241429B2Feb 8, 2022
Method of treating metabolic disorders and depression with dopamine receptor agonists
VEROSCIENCE LLC10 citations86
US11045464B2Jun 29, 2021
Parenteral formulations of dopamine agonists
VEROSCIENCE LLC10 citations86
US10894791B2Jan 19, 2021
Composition and method for treating metabolic disorders
VEROSCIENCE LLC10 citations86
US11666567B2Jun 6, 2023
Bromocriptine formulations
VEROSCIENCE LLC4 citations85
US10688155B2Jun 23, 2020
Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders
VEROSCIENCE LLC10 citations84
US10137132B2Nov 27, 2018
Parenteral formulations of dopamine agonists
VEROSCIENCE LLC10 citations84
US9999653B2Jun 19, 2018
Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders
VEROSCIENCE LLC11 citations84
US9895422B2Feb 20, 2018
Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders
VEROSCIENCE LLC10 citations84
US9415005B2Aug 16, 2016
Parenteral formulations of dopamine agonists
VEROSCIENCE LLC13 citations84
US9364515B2Jun 14, 2016
Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders
VEROSCIENCE LLC13 citations84
US12492198B2Dec 9, 2025
Composition and method for treating metabolic disorders
VEROSCIENCE LLC0 citations63
US12357693B2Jul 15, 2025
Method for inducing tumor regression
VEROSCIENCE LLC0 citations63
US12318451B2Jun 3, 2025
Method for inducing tumor regression
VEROSCIENCE LLC0 citations63
US12274698B2Apr 15, 2025
Bromocriptine formulations
VEROSCIENCE LLC0 citations63